HomeHealthcare & Life SciencesMedical Devices Radiopharmaceutical Synthesizer Market

United States Radiopharmaceutical Synthesizer Market Size & Outlook, 2025-2033


United States Radiopharmaceutical Synthesizer Market Insights

  • According to Reed Intelligence analysis, the United States Radiopharmaceutical Synthesizer Market size was USD 712.92 Million in 2024 and is projected to reach USD 1036.27 Million by 2033.
  • The United States market is projected to grow at a CAGR of 4.26% between 2026 and 2033.
  • By segment, PET emerged as the largest Modality in terms of market size in 2024.
  • Others is anticipated to remain the most attractive Modality segment, recording the fastest growth during the forecast period.

Other Key Findings


  • United States contributed 22.78% to the global Radiopharmaceutical Synthesizer Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Radiopharmaceutical Synthesizer Market.
  • In North America, United States is projected to capture the leading share of market size by 2033.
  • Among North America markets, Canada is expected to post the fastest growth, reaching USD 373.03 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 712.92 Million
Market Size In 2033 USD 1036.27 Million
Largest segment PET
Units Revenue in USD Million
CAGR 4.26% (2025-2033)
Segmnetation Covered
Modality
  1. PET
  2. SPECT
  3. Others
Application
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
Radioisotope
  1. Fluorine-18
  2. Carbon-11
  3. Gallium-68
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports